Submit Search
Upload
M&A Due Diligence List Pharma Biotech December 2022.pptx
•
Download as PPTX, PDF
•
0 likes
•
580 views
Objective Capital Partners, LLC
Follow
M&A Diligence list for life sciences companies
Read less
Read more
Business
Report
Share
Report
Share
1 of 26
Download now
Recommended
Quality Considerations in Due Diligence for Pharmaceutical Transactions
Quality Considerations in Due Diligence for Pharmaceutical Transactions
Michael Swit
Pharma-CRO Relationships Managing Risk A Lawyer\'s View
Pharma-CRO Relationships Managing Risk A Lawyer\'s View
albinpaul
Global Clinical Trials: Best Practices & Common Pitfalls
Global Clinical Trials: Best Practices & Common Pitfalls
Imperial CRS
Pharma business models
Pharma business models
Khushboo Gurjar
Database Designing in Clinical Data Management
Database Designing in Clinical Data Management
ClinosolIndia
How to create edit checks in medidata rave painlessly
How to create edit checks in medidata rave painlessly
Weihong Yang
Centralized vs. Onsite Monitoring
Centralized vs. Onsite Monitoring
IMARC Research
Decentralized Clinical Trials, presentaiton by Craig Lipset for mHealth Israel
Decentralized Clinical Trials, presentaiton by Craig Lipset for mHealth Israel
Levi Shapiro
Recommended
Quality Considerations in Due Diligence for Pharmaceutical Transactions
Quality Considerations in Due Diligence for Pharmaceutical Transactions
Michael Swit
Pharma-CRO Relationships Managing Risk A Lawyer\'s View
Pharma-CRO Relationships Managing Risk A Lawyer\'s View
albinpaul
Global Clinical Trials: Best Practices & Common Pitfalls
Global Clinical Trials: Best Practices & Common Pitfalls
Imperial CRS
Pharma business models
Pharma business models
Khushboo Gurjar
Database Designing in Clinical Data Management
Database Designing in Clinical Data Management
ClinosolIndia
How to create edit checks in medidata rave painlessly
How to create edit checks in medidata rave painlessly
Weihong Yang
Centralized vs. Onsite Monitoring
Centralized vs. Onsite Monitoring
IMARC Research
Decentralized Clinical Trials, presentaiton by Craig Lipset for mHealth Israel
Decentralized Clinical Trials, presentaiton by Craig Lipset for mHealth Israel
Levi Shapiro
Clinical trials flow process
Clinical trials flow process
Tamer Hifnawy
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...
Montrium
Pharmaceutical Contract Manufacturing
Pharmaceutical Contract Manufacturing
Farhad Zargari
Clinical data-management-overview
Clinical data-management-overview
Acri India
The Consulting-Interview - Case Interview Dos and Donts
The Consulting-Interview - Case Interview Dos and Donts
squeaker.net
Data management & statistics in clinical trials
Data management & statistics in clinical trials
International Islamic University Malaysia
Clinical Data Management
Clinical Data Management
Shray Jali
Pharmaceutical Sector in India and Pakistan
Pharmaceutical Sector in India and Pakistan
Sustainable Development Policy Institute
Clinical Data Management Process Overview_Katalyst HLS
Clinical Data Management Process Overview_Katalyst HLS
Katalyst HLS
How to Make a Data Governance Program that Lasts
How to Make a Data Governance Program that Lasts
DATAVERSITY
Outsourcing in pharma
Outsourcing in pharma
Harishankar Sahu
The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...
Office of Health Economics
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
BIS Research Inc.
Oracle Clinical Overview_Katalyst HLS
Oracle Clinical Overview_Katalyst HLS
Katalyst HLS
Budgeting study
Budgeting study
Pratigya Mathur
CRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: Clinical
Manjusha Chowdhury
Merck - Strategic Plan.docx
Merck - Strategic Plan.docx
JaswanthSeera
Clinical Data Management Interview question Part II.
Clinical Data Management Interview question Part II.
ClinosolIndia
What is Signal Management?
What is Signal Management?
Perficient
Risk Based Monitoring in Clinical Trials.
Risk Based Monitoring in Clinical Trials.
ClinosolIndia
0000950170-22-004409.pdf
0000950170-22-004409.pdf
MuhammadUmer996317
Slfrs city housing
Slfrs city housing
Deshapriya Senanayake
More Related Content
What's hot
Clinical trials flow process
Clinical trials flow process
Tamer Hifnawy
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...
Montrium
Pharmaceutical Contract Manufacturing
Pharmaceutical Contract Manufacturing
Farhad Zargari
Clinical data-management-overview
Clinical data-management-overview
Acri India
The Consulting-Interview - Case Interview Dos and Donts
The Consulting-Interview - Case Interview Dos and Donts
squeaker.net
Data management & statistics in clinical trials
Data management & statistics in clinical trials
International Islamic University Malaysia
Clinical Data Management
Clinical Data Management
Shray Jali
Pharmaceutical Sector in India and Pakistan
Pharmaceutical Sector in India and Pakistan
Sustainable Development Policy Institute
Clinical Data Management Process Overview_Katalyst HLS
Clinical Data Management Process Overview_Katalyst HLS
Katalyst HLS
How to Make a Data Governance Program that Lasts
How to Make a Data Governance Program that Lasts
DATAVERSITY
Outsourcing in pharma
Outsourcing in pharma
Harishankar Sahu
The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...
Office of Health Economics
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
BIS Research Inc.
Oracle Clinical Overview_Katalyst HLS
Oracle Clinical Overview_Katalyst HLS
Katalyst HLS
Budgeting study
Budgeting study
Pratigya Mathur
CRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: Clinical
Manjusha Chowdhury
Merck - Strategic Plan.docx
Merck - Strategic Plan.docx
JaswanthSeera
Clinical Data Management Interview question Part II.
Clinical Data Management Interview question Part II.
ClinosolIndia
What is Signal Management?
What is Signal Management?
Perficient
Risk Based Monitoring in Clinical Trials.
Risk Based Monitoring in Clinical Trials.
ClinosolIndia
What's hot
(20)
Clinical trials flow process
Clinical trials flow process
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...
Pharmaceutical Contract Manufacturing
Pharmaceutical Contract Manufacturing
Clinical data-management-overview
Clinical data-management-overview
The Consulting-Interview - Case Interview Dos and Donts
The Consulting-Interview - Case Interview Dos and Donts
Data management & statistics in clinical trials
Data management & statistics in clinical trials
Clinical Data Management
Clinical Data Management
Pharmaceutical Sector in India and Pakistan
Pharmaceutical Sector in India and Pakistan
Clinical Data Management Process Overview_Katalyst HLS
Clinical Data Management Process Overview_Katalyst HLS
How to Make a Data Governance Program that Lasts
How to Make a Data Governance Program that Lasts
Outsourcing in pharma
Outsourcing in pharma
The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
Webinar on Biomanufacturing 4.0 – A New Era in Cell and Gene Therapy Development
Oracle Clinical Overview_Katalyst HLS
Oracle Clinical Overview_Katalyst HLS
Budgeting study
Budgeting study
CRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: Clinical
Merck - Strategic Plan.docx
Merck - Strategic Plan.docx
Clinical Data Management Interview question Part II.
Clinical Data Management Interview question Part II.
What is Signal Management?
What is Signal Management?
Risk Based Monitoring in Clinical Trials.
Risk Based Monitoring in Clinical Trials.
Similar to M&A Due Diligence List Pharma Biotech December 2022.pptx
0000950170-22-004409.pdf
0000950170-22-004409.pdf
MuhammadUmer996317
Slfrs city housing
Slfrs city housing
Deshapriya Senanayake
chapter_05.ppt
chapter_05.ppt
Dr. Ahmed Hassan, PhD, DBA, PMP
INTRODUCTIONAnnual Report Analysis Projectis designed to get y.docx
INTRODUCTIONAnnual Report Analysis Projectis designed to get y.docx
BHANU281672
Knowledge level icab class lectures
Knowledge level icab class lectures
Sazzad Hossain, ITP, MBA, CSCA™
B ias 1
B ias 1
FrewGenAccount
Checklist financial due diligence
Checklist financial due diligence
pooja10thakkar
jFrog.pdf
jFrog.pdf
MarkLobo14
PHX Investor Presentation February 2023
PHX Investor Presentation February 2023
PanhandleOilandGas
PHX Corporate Presentation March 2024 Final
PHX Corporate Presentation March 2024 Final
PanhandleOilandGas
Corporate Disclosure .ppt
Corporate Disclosure .ppt
sonukam1
XBRL
XBRL
PR Newswire Israel
XBRL - 6 June 2011
XBRL - 6 June 2011
PR Newswire Israel
Latest Amendments to Companies Act 2013
Latest Amendments to Companies Act 2013
Abhishek Murali
Accountzzzzzz.......
Accountzzzzzz.......
hiral oza
Corporate reporitng requirements
Corporate reporitng requirements
gayatri malik
Accounting Standard ver 1.3.ppt
Accounting Standard ver 1.3.ppt
Abdussalam Alsumairi
William blair-35th-annual-growth-stock-conference
William blair-35th-annual-growth-stock-conference
Quintiles2014
Sidoti conference march 2018 final
Sidoti conference march 2018 final
ADAESIR
Quintiles william blair-35th-annual-growth-stock-conference
Quintiles william blair-35th-annual-growth-stock-conference
patyi_2000
Similar to M&A Due Diligence List Pharma Biotech December 2022.pptx
(20)
0000950170-22-004409.pdf
0000950170-22-004409.pdf
Slfrs city housing
Slfrs city housing
chapter_05.ppt
chapter_05.ppt
INTRODUCTIONAnnual Report Analysis Projectis designed to get y.docx
INTRODUCTIONAnnual Report Analysis Projectis designed to get y.docx
Knowledge level icab class lectures
Knowledge level icab class lectures
B ias 1
B ias 1
Checklist financial due diligence
Checklist financial due diligence
jFrog.pdf
jFrog.pdf
PHX Investor Presentation February 2023
PHX Investor Presentation February 2023
PHX Corporate Presentation March 2024 Final
PHX Corporate Presentation March 2024 Final
Corporate Disclosure .ppt
Corporate Disclosure .ppt
XBRL
XBRL
XBRL - 6 June 2011
XBRL - 6 June 2011
Latest Amendments to Companies Act 2013
Latest Amendments to Companies Act 2013
Accountzzzzzz.......
Accountzzzzzz.......
Corporate reporitng requirements
Corporate reporitng requirements
Accounting Standard ver 1.3.ppt
Accounting Standard ver 1.3.ppt
William blair-35th-annual-growth-stock-conference
William blair-35th-annual-growth-stock-conference
Sidoti conference march 2018 final
Sidoti conference march 2018 final
Quintiles william blair-35th-annual-growth-stock-conference
Quintiles william blair-35th-annual-growth-stock-conference
Recently uploaded
Call Girls in Mehrauli Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Mehrauli Delhi 💯Call Us 🔝8264348440🔝
soniya singh
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
lizamodels9
Progress Report - Oracle Database Analyst Summit
Progress Report - Oracle Database Analyst Summit
Holger Mueller
Case study on tata clothing brand zudio in detail
Case study on tata clothing brand zudio in detail
Ariel592675
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Stunning ➥8448380779▻ Call Girls In Hauz Khas Delhi NCR
CATALOG cáp điện Goldcup (bảng giá) 1.4.2024.PDF
CATALOG cáp điện Goldcup (bảng giá) 1.4.2024.PDF
Orient Homes
Lean: From Theory to Practice — One City’s (and Library’s) Lean Story… Abridged
Lean: From Theory to Practice — One City’s (and Library’s) Lean Story… Abridged
KaiNexus
FULL ENJOY - 9953040155 Call Girls in Chhatarpur | Delhi
FULL ENJOY - 9953040155 Call Girls in Chhatarpur | Delhi
MalviyaNagarCallGirl
Banana Powder Manufacturing Plant Project Report 2024 Edition.pptx
Banana Powder Manufacturing Plant Project Report 2024 Edition.pptx
georgebrinton95
Catalogue ONG NUOC PPR DE NHAT .pdf
Catalogue ONG NUOC PPR DE NHAT .pdf
Orient Homes
NewBase 22 April 2024 Energy News issue - 1718 by Khaled Al Awadi (AutoRe...
NewBase 22 April 2024 Energy News issue - 1718 by Khaled Al Awadi (AutoRe...
Khaled Al Awadi
Cash Payment 9602870969 Escort Service in Udaipur Call Girls
Cash Payment 9602870969 Escort Service in Udaipur Call Girls
Apsara Of India
M.C Lodges -- Guest House in Jhang.
M.C Lodges -- Guest House in Jhang.
Aaiza Hassan
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
noida100girls
Vip Female Escorts Noida 9711199171 Greater Noida Escorts Service
Vip Female Escorts Noida 9711199171 Greater Noida Escorts Service
ankitnayak356677
(8264348440) 🔝 Call Girls In Mahipalpur 🔝 Delhi NCR
(8264348440) 🔝 Call Girls In Mahipalpur 🔝 Delhi NCR
soniya singh
The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024
christinemoorman
A.I. Bot Summit 3 Opening Keynote - Perry Belcher
A.I. Bot Summit 3 Opening Keynote - Perry Belcher
Perry Belcher
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
lizamodels9
Investment analysis and portfolio management
Investment analysis and portfolio management
JunaidKhan750825
Recently uploaded
(20)
Call Girls in Mehrauli Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Mehrauli Delhi 💯Call Us 🔝8264348440🔝
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Lowrate Call Girls In Sector 18 Noida ❤️8860477959 Escorts 100% Genuine Servi...
Progress Report - Oracle Database Analyst Summit
Progress Report - Oracle Database Analyst Summit
Case study on tata clothing brand zudio in detail
Case study on tata clothing brand zudio in detail
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
CATALOG cáp điện Goldcup (bảng giá) 1.4.2024.PDF
CATALOG cáp điện Goldcup (bảng giá) 1.4.2024.PDF
Lean: From Theory to Practice — One City’s (and Library’s) Lean Story… Abridged
Lean: From Theory to Practice — One City’s (and Library’s) Lean Story… Abridged
FULL ENJOY - 9953040155 Call Girls in Chhatarpur | Delhi
FULL ENJOY - 9953040155 Call Girls in Chhatarpur | Delhi
Banana Powder Manufacturing Plant Project Report 2024 Edition.pptx
Banana Powder Manufacturing Plant Project Report 2024 Edition.pptx
Catalogue ONG NUOC PPR DE NHAT .pdf
Catalogue ONG NUOC PPR DE NHAT .pdf
NewBase 22 April 2024 Energy News issue - 1718 by Khaled Al Awadi (AutoRe...
NewBase 22 April 2024 Energy News issue - 1718 by Khaled Al Awadi (AutoRe...
Cash Payment 9602870969 Escort Service in Udaipur Call Girls
Cash Payment 9602870969 Escort Service in Udaipur Call Girls
M.C Lodges -- Guest House in Jhang.
M.C Lodges -- Guest House in Jhang.
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
BEST Call Girls In Old Faridabad ✨ 9773824855 ✨ Escorts Service In Delhi Ncr,
Vip Female Escorts Noida 9711199171 Greater Noida Escorts Service
Vip Female Escorts Noida 9711199171 Greater Noida Escorts Service
(8264348440) 🔝 Call Girls In Mahipalpur 🔝 Delhi NCR
(8264348440) 🔝 Call Girls In Mahipalpur 🔝 Delhi NCR
The CMO Survey - Highlights and Insights Report - Spring 2024
The CMO Survey - Highlights and Insights Report - Spring 2024
A.I. Bot Summit 3 Opening Keynote - Perry Belcher
A.I. Bot Summit 3 Opening Keynote - Perry Belcher
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Call Girls In Sikandarpur Gurgaon ❤️8860477959_Russian 100% Genuine Escorts I...
Investment analysis and portfolio management
Investment analysis and portfolio management
M&A Due Diligence List Pharma Biotech December 2022.pptx
1.
D U E
D I L I G E N C E - M & A
2.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 2 1. TARGET COMPANY / CORPORATE MATTERS 1.1 GENERAL 1 Organizational chart and management structure 2 Charter documents, operating agreements, by-laws, business licenses, certificates of authority and stock certificates 3 Board actions and minutes 4 Information and documentation on joint ventures, acquisition and/or disposals of subsidiaries, affiliates or major assets of the company. (last five years) 5 Key contacts by function 6 Management biographies 7 The Articles of Incorporation and any amendments 8 List of company bylaws and amendments 9 List of company assumed names 10 List of all states or countries where the company does business, has employees or owns/leases an asset 11 Annual reports for the last three years 12 Copy of the company's minutes/minute book 13 List of all shareholders and percentages owned 14 A Certificate of Good Standing from each Secretary of State where the company does business 15 Active status reports in the state of incorporation over the past three years 16 Agreements on voting trusts, subscriptions, puts, calls, options and convertible securities
3.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 3 1. CORPORATE MATTERS (CON’T) 1.2 FACILITIES 1 Details on any facility openings or closings (last five years) 2 List of products and services in development 3 Correspondence and documents related to the regulatory approval of product lines 4 Tests, evaluations, studies and surveys about products or services under development 5 A list of major customers and product applications 1.3 PRODUCTS AND SERVICES 1 List of products and services offered 2 Listings of all owned and/or leased property and locations 3 Copies of deeds, mortgages, real estate leases, title policies and zoning approvals 4 Details on any facility turnarounds (last five years)
4.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 4 2. FINANCE 2.1 GENERAL 1 Internal and external audits and work papers (last five years and YTD) 2 Audit inquiry responses and opinion letters from legal counsel for the past three years 3 Consolidated financials (last five years and YTD) 4 Consolidated quarterly financials (last five years and YTD) 5 Accounting reconciliation of all accounts for the most recent balance sheet available 6 Trial balances (last five years and YTD) 7 Description of any off-balance sheet commitments 8 Description of any contingent liabilities 9 Price and volume data by division and product annually 10 Annual P&L by location (last five years and YTD) 11 Locations of accounting records and personnel 12 Accounting policies and procedures 13 Details on raw materials and currency risk management (e.g., hedging) 14 Historical and projected cost and volume of key material inputs 15 Details on cash balances including cash in different jurisdictions and accounts 16 FX details (sales and costs by currency) 17 List of Transformation Plan initiatives and savings completed and remaining 18 Details on any restructuring efforts including costs, timing, rationale and P&L impact (historical and projected) 19 5-year projection model including assumptions and granular backup 20 Acquisition pipeline for the company including strategic rationale, expected purchase price, anticipated P&L, synergies, status, timing 21 Details on new product initiatives strategy, cost and P&L impact (historical and projected) 22 Detailed CapEx schedule including breakout between maintenance, growth, and new products and acquisitions (five years historical and projected) 23 Annual profitability by customer (last five years and YTD) 24 Annual breakdown of sales, volume and gross margin by product, by region and by customer 25 Details on end-market exposure (historical and projected) 26 Adjusted EBITDA and sales bridges (last three years) 27 Detailed working capital schedule 28 Product returns, charge-backs, discounts 29 Breakdown of cost of goods sold
5.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 5 2. FINANCE (CON’T) 2.1 GENERAL 30 SG&A details 31 Business plan or most recent forecast, including projections for five years 32 Revenue and gross margins by product for past three years 33 Breakdown of operating expenses for past three years 34 Options and stock purchase agreements affecting company operations 35 Off-balance sheet liabilities 36 Explanation of supply chain and supply restrictions 37 Transportation costs 38 List of inventory systems to track incoming and outgoing goods and find obsolete goods 39 Profitability and cost structure documentation, including: 39a Expense trends over the past five years 39b Questionable expenses that can/may be cut 39c Employee loans, including pay advances or long-term loans 40 Auditor's correspondence for the past five years (these are letters sent to management that outline areas to improve profits and efficiency) 41 Company credit report 42 List of outstanding debt 42a Search for any clauses that increase debt if a company is sold 42b Scan for any related parties that have loaned money to the company (this includes management, investors and shareholders) 43 List of unrecorded liabilities, which you usually find when interviewing the seller or employees 44 Projections, capital budgets and strategic plans 44a Projections should include revenue by product type, customer and channel 44b Projections should also include all financial statements such as a balance sheet, cash flow statement and cash-on-hand 44c A list of growth drivers and possible clients and customers 44d Industry and company pricing plans 44e Analysis of projected expenditures and depreciation 44f Any perceived risk in foreign markets such as inflation, political strife and exchange rates 45 Capital structure 45a Current shares outstanding 45b A list of all stockholders with options, warrants and notes 46 A list of non-operational expenses (any companies put operating expenses in this category to pad their earnings) 47 Public filings (if the company is publicly traded, it must file a Form 10-K annual report, Form 10-Q quarterly report and other issues on the Form 8-K)
6.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 6 2. FINANCE (CON’T) 2.2 ACCOUNTS RECEIVABLE 1 Historical accounts receivable schedule 2 Top 20 past-dues 3 Details on any recognized bad debt expense, write offs and recoveries 4 A description of the company's credit policies 5 Most up-to-date A/R aging 2.3 INVENTORIES 1 Summary of the composition of inventory for last five years 2 List of products as at the most recent balance sheet date 3 Detailed inventory valuation report 4 List of inventory including the result of the last stock physical count, reconciled with the accounting balance at the date of physical count 5 Details of any inventories maintained offsite 6 Breakdown of inventory by classification (finished goods, WIP, raw materials) 7 Inventory aging
7.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 7 2. FINANCE (CON’T) 2.4 BANKS AND FINANCING 1 List of all banks with which the company maintains financial and commercial relations 2 Detailed debt schedule 3 Promissory notes 4 Loan agreements 5 Equipment/other lease agreements 6 Bank reconciliations (past three years) 2.5 FIXED ASSETS 1 Summary schedule showing the composition of the company's fixed assets (most recent data) 2 Schedule showing owned and leased assets 3 Detailed fixed asset and depreciation schedule with locations 4 List of Uniform Commercial Code (UCC) filings 5 List of leased equipment 6 List of major equipment sales and purchases over the past three years 7 Summary of depreciation policies and the economic useful lives of fixed assets, by category 8 Valuation, inspection, maintenance, utilization and replacement rate 2.6 CUSTOMERS 1 List of top 25 customers for the past two years in total, by region and by end product to the extent available 2 List of sales from top 25 customers over the past two years 3 Top 25 customer sales (last five years), with gross profit and contribution margin 4 Details on customers including number, length of relationships, concentrations 5 Customer terms and credit limits 6 Customer losses for last five years, including major customers and reasoning 7 Average customer purchase amounts
8.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 8 2. FINANCE (CON’T) 2.7 SUPPLIERS 1 Details on raw materials sourcing 2 List of suppliers with open balances at the most recent balance sheet date 3 List of overdue payable amounts as at the most recent balance sheet date 4 List of top suppliers in total, by region and by end-product to the extent available 5 List of top suppliers' terms 6 List of the company's purchasing policies 7 All current supplier and service agreements 8 Most up-to-date A/P aging 2.8 MANAGEMENT REPORTS 1 For the last five years, year-to-date management reports comparing the company's actual result (in accordance with the management books) with the year's budgeted result 2 Budgets and operating plans for future periods (particularly detailed plans) 2.9 POLICIES AND INTERNAL CONTROLS MATTERS 1 Summary of cash management policy, procedures, systems and controls 2 Details on revenue recognition policies, rebate and sales allowance policies and granting procedures 3 Details of credit granting, billing, and collection policies and procedures 4 Description of information systems 5 Hardware and software by location 6 Key reports provided to management 7 Systems interface flowchart 8 Evaluations of existing system in terms of future needs, enhancements and problem areas
9.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 9 2. FINANCE (CON’T) 2.10 RELATED PARTY TRANSACTIONS 1 Identify and provide details of all related party balances and repayment terms 2 Details of inter-company transfer pricing policy 2.11 COMPETITORS 1 List of significant competitors by end-market and region 2 Pricing trends/behavior by key competitors 3 Current market share information by competitor 4 Description of competitors including strengths, weaknesses, market position and basis of competition 5 Tracking of new business opportunities 2.12 SALES AND MARKETING 1 Information on the company's sales strategy and compensation structure associated with each channel 2 Information on the business development process (i.e., how opportunities are identified, how are bids determined, etc.) 3 List of major wins and losses over the past 12 months 4 List of articles and press releases/PR about the company within the last three years 5 Description of major marketing channels and expenditures 6 Current ad programs, marketing budgets and printed/pdf marketing materials 7 A comparative analysis that shows: 7a How the company's marketing efforts stack up against the competition 7b The company's dedication to creating/preserving a brand 8 A list of coordination protocols between the sales and marketing departments 9 List of customer complaints and resolutions 10 Incentive compensation plan(s) for sales team 11 Research on methods/plans to obtain new business 12 Surveys and research on company products 13 Lead sourcing and customer management processes
10.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 10 2. FINANCE (CON’T) 2.13 SALES STRATEGY 1 Description of global distribution channels 2 Marketing opportunities/risks 2.14 MAJOR CUSTOMERS 1 Status and relationships 2 Revenue breakdown – five-year historicals 3 Pipeline analysis 4 Quality and stability of relationships 2.15 SALES FORCE OVERVIEW 1 Compensation – five-year historical 2 Sales force productivity model that outlines: 2a Plans for new hires 2b Compensation and commission 2c Organization 2d Productivity 2e Skills match 3 Quota average 4 Sales cycle 5 Hiring schedule 6 Sales backlog by product
11.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 11 3. OPERATIONS 3 OPERATIONS 1 Key quality measures tracked for the past three years 2 Key productivity measures tracked for the last three years (i.e., revenue and output per employee, manufacturing utilization, etc.) 3 Workflow of operations 4 Order process flow (how orders are received, what details are included, how orders are shipped) 5 Monthly manufacturing yields 6 Schedule of unfilled orders 7 Product returns by customer for the past five years
12.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 12 4. CONTRACTS / LEGAL 4 CONTRACTS / LEGAL 1 Material supply and sourcing contracts 2 Material customer contracts 3 List of any guarantees, indemnifications or similar agreements 4 Any other material contracts 5 Copies of contracts between the company and directors, officers, affiliates and minimum five percent (5%) shareholders 6 Agreements and relationships with any subsidiaries, partnerships or joint ventures 7 Loan agreements, credit lines, IRBs, derivatives, letters of credit, promissory notes, security agreements, financing details, guarantees, equipment leases and other financing documents 8 All nondisclosure (NDA) and noncompete agreements 9 List of mortgages, collateral pledges, indentures and security agreements 10 Installment sales agreements 11 Guarantees involving the company at any level 12 Copies of quote, invoice, proposal, purchase and warranty documents 13 Contracts, transcripts or letters of divestitures from any merger or acquisition within the past five years 14 Power of attorney agreements 15 Exclusivity agreements 16 Franchise agreements 17 Indemnification agreements 18 Copies of federal, state and local licenses, permits and consent forms 19 All contracts or agreements providing for third party consent to this proposed transaction
13.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 13 5. LABOR / HUMAN RELATIONS 5.1 GENERAL 1 Employment agreements, applications for employment, hire letters and descriptions of oral/informal promises or commitments regarding terms of employment 2 Employee handbooks, policies and code of conduct — including policies on vacation, sick days, benefits, holidays and paid leave 3 Payrolls, together with general summary (last five years and YTD) 4 Employees by location, department, salaried vs. hourly, union vs. non-union, and current compensation and employment status 5 Employee headcount by location and function (last five years and YTD) 6 Summary of any collective bargaining agreement/union agreement (last five years and YTD) 7 Summary of any strike/work stoppages/grievances 8 Consulting, freelance and independent contractor agreements 9 List of all executives that provide services to the company, informing the corresponding remuneration (most recent) 10 Resumes, history and experience of key employees, including senior management 11 Details surrounding temporary workers that provide services to the company (e.g., starting and finishing date of providing the services, salary and working area) 12 List of self-employed people providing services to the company, containing name, initial date of provision of services, remuneration and description of the services provided (last five years and YTD) 13 List of outsourced companies providing services to the company, containing name, initial date of provision of services, amount, description of the services provided and contract terms (last five years and YTD) 14 List of all employees that work via fixed term contracts (most recent) 15 Layoff and severance package information 16 List of harassment, wrongful termination and discrimination disputes within the past three years 17 Workers’ compensation claims 18 An explanation of the company's salary philosophy 19 List of union affiliations and contracts 20 Description of any labor disputes, arbitration or grievances, settled or outstanding over the past three years 21 A list of any officers in criminal or civil litigation 22 Actuarial reports from the last three years 23 Turnover data for the past two years 24 Copies of all Occupational Safety and Health Administration (OSHA) examinations 25 Results of formal and informal employee surveys 26 Confidentiality, non-competes or similar agreements for current employees and for those currently in effect
14.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 14 5. LABOR / HUMAN RELATIONS (CON’T) 5.2 BENEFITS 1 List of the benefits, both formal and informal, given to employees, directors and officers (most recent) 2 Equity-based compensation plans 3 All compensation agreements covering senior management 4 Severance benefit plans and other change-of-control agreements 5 Pension/OPEB detail including most recent actuarial reports 6 Profit sharing plan 7 Unemployment claims history 8 Pay history and pay freeze information 9 Summary biographies of senior management, including employment history, service with the company, years in current position) 10 Bonuses paid out for the past three years 11 Loans to employees, including from benefit plan 12 Qualified plans (pension, profit sharing, stock bonus, ESOP) 13 All plans maintained or contributed to 14 Trust, annuity, guaranteed investment, or other funding vehicles and investment advisor contracts 15 IRS determination letters, with applications 16 Form 5500 and supplementary materials for past three years 17 Summary plan descriptions for all plans 18 Most up-to-date Trustee report for all plans 19 Fiduciary liability policies and fidelity bond 20 Current actuarial reports for defined benefit plans 21 All plans, booklets, policies and contracts for health, life, disability, workers' compensation and other insurance-type benefits 22 Current list of employee and employer contributions or monthly premium rates (with COBRA rates) for health and life insurance plans and gross premiums during last 24 months 23 Estimate of present value of post-retirement health and life insurance liability for current retirees and the emerging liability for future retirees 24 Claims experience reports and related data (claims reserves, etc.) for last 24 months for health and life insurance plans broken down between retirees and active employees 25 Date of hire of each employee and former employee entitled to health or life insurance benefits, and type of coverage being provided 26 Non-qualified deferred compensation arrangements and incentive and bonus plans 27 Evidence of compliance with IRS Section 409A in regard to stock options 28 Evidence of compliance with IRS Section 280G in connection with the purchase 29 Unemployment insurance arrangements, claims experience 30 Attorneys’ responses to auditors’ requests in connection with plan audits for last three years
15.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 15 6. TAXES 6.1 GENERAL 1 All applicable tax returns filed for the last five years (federal, state, local, property and foreign) 2 Detailed explanations of general accounting principles 3 Details on any deferred tax assets and liabilities 4 Details on any non-deductible expenses 5 Reconciliation from marginal to effective tax rate 6 Nature and location of assets of the corporation and their respective fair market values and tax bases 7 Federal or state tax audits and supplementary materials 8 Schedule of financing for debt and equity 9 Property taxes paid for past three years 10 List of any tax liens 11 IRS Form 5500 for 401k plans 12 Excise tax filings for the past five years 13 All audit reports and employment tax filings for the past five years 14 Tax settlement documents over the past three years 15 Transfer pricing, strategy, analysis and advice received 16 List of undisclosed tax liabilities 17 International income tax planning, strategy, analysis and advice received
16.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 16 7. ENVIRONMENTAL 7.1 GENERAL 1 Copies of environmental audits and compliance reports for each company property 2 List describing or identifying any environmental liabilities or contingencies 3 Phase 1 reports for all facilities 4 Environmental liabilities and valuation 5 Prior ownership of facilities 6 Costs for environmental compliance 7 List of hazardous wastes or hazardous materials used in production 8 Description of company disposal methods for hazardous materials, recyclables, etc. 9 List of terminated licenses or permits 10 List of any superfund exposure 11 Copies of notices or filings with the Environmental Protection Agency (EPA) 12 List of any environmental investigations and pending litigation 13 Notices of violations received in the past three years
17.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 17 8. REGULATORY & LEGAL 8.1 GENERAL 1 All permits and licenses 2 All compliance reports 3 Any deficiency notices 4 All pending lawsuits against the company — details, all court records, contingency planning 5 All pending lawsuits initiated by the company — details, all court records, contingency planning 6 Any pending or potential antitrust issues as a result of the purchase 7 Historical and current regulatory issues/information requests/settlements 8 Any prior or historical antitrust issues 9 Any issues involved in a Hart-Scott-Rodino filing with the Federal Trade Commission (FTC) 10 Any Exon-Florio issues for national security and foreign investment 11 A list of Department of Commerce filings 12 All reports submitted to regulatory agencies 13 OSHA inspection reports 14 Documentation regarding any governmental actions, investigations or proceedings regarding the corporation for the past three years
18.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 18 8. REGULATORY & LEGAL (CON’T) 8.2 INSURANCE 1 Current schedule of insurance listing each insurance in force, insurance company, type of coverage, term of policy, insured value or limits of liability and annual premium, including but not limited to: 1a Worker's compensation 1b General liability 1c Personal and property 1d Directors and officers 1e Errors and omissions 1f Key-man 1g Product liability 1h D&O 1i E&O 1j Vehicle 1k Intellectual property 2 Documentation regarding insurance claims and coverage denials in the last three years, including all correspondence in regard thereto 3 Insurance costs for the most recent year 4 If self-insured, details of claims paid for the last three years and the most recent interim period 5 With respect to general liability and products liability, estimated sales of the company and loss history 6 With respect to workers compensation, estimated annual payroll by class (8810-Clerical [including Executives]; 8742-Sales; 8010-Warehouse) 7 List of all company vehicles and a list of drivers containing name and driver’s license state and number 8 Insurance carrier inspection reports
19.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 19 9. LITIGATION 9.1 GENERAL 1 Summary of all material litigation for the last five years 2 A list of all pending litigation and descriptions of any threatened litigation 3 Consolidated financials (last five years and YTD) 4 Documentation of any significant litigation in process or anticipated 5 Pleadings and other material documentation (including evaluations of claims made internally or by counsel) in pending lawsuits by or against the corporation 6 Copies of current consent decrees, orders, injunctions, administrative decrees or judgments against the corporation 7 A list of unsatisfied judgements 8 Copies of insurance policies that protect against litigation 9 Any documents pertaining to proceedings with a regulatory agency 10 History of any problems with regulatory bodies, such as the IRS or SEC 11 A review of all board minutes, shareholder minutes and audit minutes 12 Listing of unsold inventory of products involved in any current trademark or patent litigation
20.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 20 9. LITIGATION 9.2 CLAIMS 1 Documentation regarding pending claims of any kind by or against the corporation (e.g., breach of contract, competition, infringement of proprietary rights, toxic tort and environmental, whether in the U.S. or abroad, and customer complaint file) 2 Product liability claim 3 Summary of complaints and any warranty claims 4 Internal documentation regarding product recalls or health/safety advisories
21.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 21 10. INTELLECTUAL PROPERTY 10.1 TRADEMARKS AND COPYRIGHTS 1 List of all trademarks and copyrights — foreign and domestic 2 Unregistered trademarks (owned or claimed) 3 List of tradenames — foreign and domestic 10.2 PATENTS/INDUSTRIAL DESIGNS 1 List of all patents and other IP — foreign and domestic 2 List of all patent applications — foreign and domestic 3 Patent clearance documents 4 Summary of claims or threatened claims on intellectual property 10.3 SOFTWARE/IT 1 Description of all technical information within the company 2 List and describe significant software, hardware and IT systems used to operate the company that generate financial and management reporting 3 List of software licenses bought to analyze other companies and for other use cases 4 List of interfaces that link systems together 5 Current system usage and age of equipment 6 Level of customization of existing software 7 Existing or planned outsourcing agreements with other IT companies 8 Perform a full analysis of the system 9 An outline of a disaster recovery plan should systems crash or become damaged
22.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 22 10. INTELLECTUAL PROPERTY (CON’T) 10.4 LAWSUIT AND LITIGATION 1 Any material IP litigation 10.5 NEW PRODUCT DEVELOPMENT AND TECHNOLOGY 1 Details on historical and projected R&D 2 Details on new product initiatives 10.6 BRANDS 1 Owned brands 2 Copies of licensing/royalty agreements and contractual terms 10.7 OTHER INFORMATION 1 Non-registered proprietary processes, trade secrets, inventions, know-how or other proprietary information owned or used 2 Licenses of proprietary rights (as licensor or licensee) 3 Confidentiality agreements and ownership of invention agreements 4 Work-for-hire agreements 5 Copies of all consulting agreements, invention agreements and licenses of intellectual property to and from the company 6 List of all licensing revenue and expenses 7 Pending or threatened infringement claims, opposition or cancellation proceedings
23.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 23 11. REAL PROPERTY 11.1 GENERAL 1 List of all real estate, condition of facilities and needs to major expenditures to maintain/upgrade 2 Real estate valuation reports (including building, inventory, furniture/fixtures) 3 Title reports and property surveys 4 Vehicle fleet details as applicable 5 Major fixed assets and equipment 6 Properties held for sale 7 Lease/sublease agreements 8 Notices/relevant correspondences, including side letters or agreements, alleged defaults, renewal of leases, easements/encumbrances 9 Contracts for capital improvements
24.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 24 12. INDUSTRY 12.1 GENERAL 1 Information on the company's end-markets 2 Information on key industry drivers 3 Market size/potential 4 Legislative or regulatory information affecting the industry as a whole 5 Internal/external reports, articles and/or white papers analyzing the market 6 Key competitors by channel, including estimated revenue, marketing share, major customers, strategic priorities, etc. 7 Speed and nature of change within the industry 12.2 RESEARCH & DEVELOPMENT 1 R&D organizational overview 2 Key personnel 3 Title reports, roadmaps and property surveys 4 New product/service pipeline 5 Development costs 6 MVP status 7 Product development process
25.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 25 • Regulatory Affairs • Submissions & Meetings • Agencies • FDA • EMEA • Other • CMC / Manufacturing & Supply • Product Development • Preclinical development • Clinical development • Pricing and Reimbursement 13. OTHER (INDUSTRY SPECIFIC)
26.
COPYRIGHT © 2021
CARDIFF ADVISORY HEALTHCARE & LIFE SCIENCES 26 Footer SECURE A BETTER FUTURE FOR YOUR COMPANY (858) 245 - 4905 david.crean@cardiffadvisory.com David H. Crean, Ph.D.* Managing Partner Contact us to learn more: Ensure the growth or exit of your business is handled with the expertise and resources necessary for success *Registered representative of BA Securities, LLC Member FINRA SIPC, located at Four Tower Bridge, 200 Barr Harbor Drive, Suite 400 W. Conshohocken, PA 19428. Cardiff Advisory LLC and BA securities, LLC are unaffiliated entities. All investment banking services and securities are offered through BA Securities, LLC, Member FINRA SIPC.
Download now